Last reviewed · How we verify
NCT03196544
Novel Behavioral Intervention to Enhance Social Connections in Anxiety and Depression
NA trial testing Social Approach Training (5 sessions) in Anxiety Disorders and Symptoms in 75 participants. Completed in 1 April 2020.
8 October 2019
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 3 April 2018 |
| Primary completion | 8 October 2019 |
| Estimated completion | 1 April 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Social Approach Training (5 sessions)
- Social Approach Training (10 sessions)
Conditions studied
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
- Depression — all drugs for Depression →
Sponsor
University of California, San Diego
Who can join
Adults 18 to 55, any sex, with Anxiety Disorders and Symptoms or Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overall goal of this project is to develop a novel transdiagnostic behavioral treatment -- social approach training -- intended to enhance positive social connections in individuals with elevated anxiety and/or depression. Social relationship impairments are pervasive and debilitating consequences of anxiety and depression. Existing treatments have some beneficial impact on social functioning; however, many people continue to have few and/or poor quality relationships following treatment, even after experiencing symptom relief. This study will evaluate the effects of social approach training on the brain systems that have been shown to be important for establishing positive connections with others. Approximately 60 individuals (ages 18-55) seeking treatment for anxiety or depression will participate in this study. Participants will be randomly assigned with equal probability to one of two versions of social approach training (5 or 10 sessions) or a waitlist (assessment only) control group. Participants will be assessed at baseline and post-treatment and compared on measures assessing brain responses to social reward (primary outcome), as well as physiological, behavioral, and emotional responses to social reward (secondary outcomes). It is hypothesized that participants assigned to social approach training will display greater increases from pre- to post-treatment in activity in brain systems that regulate the processing of social reward (e.g., striatum) relative to participants in the control group. This study will also determine whether the 5- vs. 10-session versions of the treatment program result in meaningful differences, compared to each other, in how the brain responds to social reward.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Amplification of Positivity Treatment for Anxiety and Depression: A Randomized Experimental Therapeutics Trial Targeting Social Reward Sensitivity to Enhance Social Connectedness.
Taylor CT, Stein MB, Simmons AN, He F, et al · · 2024 · cited 30× · PMID 37607657 · DOI 10.1016/j.biopsych.2023.07.024 -
Beyond Positive Affect: Discrete Positive Emotions Differentiate Major Depression from Social Anxiety Disorder.
Chin AA, Sweet AM, Taylor CT. · · 2023 · cited 4× · PMID 37179573 · DOI 10.1007/s10608-023-10355-y -
Validation of the Approach-Avoidance Temperament Questionnaire in Individuals with Anxiety and Depression.
Rassaby M, Rogers JM, Taylor CT. · · 2025 · cited 3× · PMID 38776435 · DOI 10.1080/00223891.2024.2350466 -
Application of an egocentric social network approach to examine changes in social connections following treatment for anxiety and depression: A novel measurement tool for clinical trials research?
Rassaby M, Shakya HB, Fowler JH, Oveis C, et al · · 2024 · cited 2× · PMID 38696938 · DOI 10.1016/j.socscimed.2024.116914 -
Network analyses of discrete emotions and social connectedness indicators in anxiety and depressive disorders.
Shriver RC, Rassaby M, Collins AC, Taylor CT. · · 2026 · PMID 42027952 · DOI 10.1016/j.xjmad.2026.100177 -
Differential associations of childhood abuse and neglect with neural responses to social reward and punishment in adults with anxiety or depression.
Spaulding IG, Stein MB, Taylor CT. · · 2026 · PMID 41651812 · DOI 10.1038/s41398-026-03881-2 -
The power of positivity: Exploring affective and social processes of change throughout a positive valence treatment for anxiety or depression.
Rassaby M, Adams SN, Stein MB, Taylor CT. · · 2025 · PMID 40988653 · DOI 10.1016/j.xjmad.2025.100146 -
Amplification of positivity for depression and anxiety: Neural prediction of treatment response.
Kryza-Lacombe M, Spaulding I, Ku CK, Pearson N, et al · · 2024 · PMID 38714105 · DOI 10.1016/j.brat.2024.104545
Verify or expand the search:
- PubMed search for NCT03196544
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Disorders and Symptoms
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT05821634 — Personalizing Treatment Delivery · NA · recruiting
- NCT06138730 — Evaluating a Virtual Mentoring Program Plus Mental Health Videos for Teens · NA · active not recruiting
- NCT06356090 — SPACE: a Parent-based Treatment for Pediatric OCD · NA · recruiting
- NCT05836090 — Family Spirit Strengths · NA · recruiting
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03196544 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 28 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03196544.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing